Eliza Jennings is dedicated to the health and safety of those we serve and are taking precautions based on Centers for Medicare and Medicaid Services requirements.

Yes. We welcome volunteers to assist with escorting Eliza Jennings residents to and from their sessions.

To find out more about SAIDO Learning at Eliza Jennings, please contact 216.325.1266.

We believe every person should have equal access to these innovative treatments, and are seeking foundation support to fund SAIDO for residents who are unable to pay privately, until government funding becomes available.

Supporters work closely with resident Learners. They are Eliza Jennings employees from all professional disciplines, including nursing, administration, dietary, housekeeping, activities and maintenance. Supporters attend three days of intensive training on all aspects of the therapy: the founding principles; education on the pre-frontal cortex and how it relates to the therapy; how to assign Learners to appropriate levels of learning; and coaching techniques, positive reinforcement, and the role of the rest of the community in supporting the therapy.

For optimum results and continued improvement, SAIDO Learning has been demonstrated to work best in a community setting on a long-term basis. Once an individual discontinues participation, dementia symptoms are likely to return and increase.

SAIDO Learning has been determined to be the most effective when performed five times per week. It is most successful when performed in a residential community where older adults receive ongoing staff support from all disciplines. The therapy is currently not available in the home.

All of the Learners in the Eliza Jennings trial experienced some degree of improvement in at least one of the two standardized tests for cognitive ability, the FAB, and the MMSE.

Whether great or small, we are seeing positive changes within the first month of participation. Improvements resulting from participation are likely to continue throughout the duration of the older adults’ sessions.

A successful candidate is an individual with a diagnosis of moderate-stage dementia who is able to participate in therapy sessions. The therapy can also be provided bedside for individuals whose cognitive impairments are more severe.

An individual with any form and/or stage of dementia (other than alcohol-induced dementia) can benefit.